Fig. 3: Overall survival (OS) amongst patients that never received immunotherapy (n = 272).
From: PD-1 transcriptomic landscape across cancers and implications for immune checkpoint blockade outcome
Kaplan–Meier analysis of OS from the time of metastatic/advanced disease. High transcript expression indicates ≥75th expression percentile rank. Moderate/low transcript expression indicates <75th percentile expression rank. This graph demonstrates that there is not a statistically significant difference in survival between those who have high vs moderate/low PD-1 expression, indicating lack of significant prognostic effect. P value was derived from log-rank test.
